A prospective, observational, multicenter study analysing initial experience with reversal of direct oral anticoagulants in trauma patients
Latest Information Update: 28 Sep 2021
At a glance
- Drugs Andexanet alfa (Primary) ; Factor VIII inhibitor bypassing fraction (Primary) ; Idarucizumab (Primary) ; Prothrombin complex concentrate (Primary)
- Indications Blood coagulation disorders
- Focus Therapeutic Use
- 28 Sep 2021 New trial record
- 01 Aug 2021 Primary endpoint has been met. (mortality), as per Results published in the American Journal of Surgery
- 01 Aug 2021 Results published in the American Journal of Surgery